Best CGT Podcasts (2024)

1
129. Using the 6 Year CGT Rule on an Investment Property 3:53

20h ago3:53

3:53

Fan Mail - Send us a Text Message Today’s topic is using the 6 year CGT rule on an investment property. www.structuring.com.auBy Terryw

1
Setting Up a Robust CGT Supply Chain (Part 1) 18:18

3d ago18:18

18:18

Cell & Gene Therapies hold incredible potential for improving – if not saving – human lives. These CGT’s have been called “living drugs” and can heal diseased organs and – we hope – fight diseases that currently have no cure. Because of these incredible possibilities, related research and development is growing exponentially around the globe, with …

1
TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D. 35:30

4h ago35:30

35:30

We love to hear from our listeners. Send us a message. KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Erin Harris to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have the potential to treat a variety of solid tumor types. Benson explains KSQ's Phase 1/2 clinical study, KSQ-001EX, which consists of TILs in which the S…

1
I&P Podcast #6: Getting it right first time – the importance of policy ownership with Gregor Sked, Royal London 15:53

2d ago15:53

15:53

Insurance and protection as part of financial planning can often be overlooked or treated as an afterthought when in reality it should form part of the cornerstone of financial planning for many clients. So, on this week’s podcast Jenny and Brandon focus on insurance and protection, and in particular policy ownership, with their guest Gregor Sked, …

1
Behind the numbers: Groupthink – the boardroom’s most pervasive problem? 39:55

7d ago39:55

39:55

In this episode of Behind the Numbers, we discuss strategies to prevent and tackle groupthink at board level. By suppressing debate and disrupting effective decision-making, groupthink poses a significant governance challenge for firms. Notably, the recent scandal over fee transparency at wealth manager St James’s Place – which has set aside £426m …

1
Podcast #84: What does the FCA’s Retirement income review mean for advisers? With BNY Investments’ Richard Parkin 20:56

8d ago20:56

20:56

Has your client retirement proposition evolved following the publication of the FCA's thematic review of retirement income advice? In March, the FCA wrote to the Chief Executives of financial advice firms asking them to review their processes when providing retirement income advice. This thematic review has pretty massive implications for the advic…

1
128. The Need to Pay a Loan Down in Full When Debt Recycling 4:09

10d ago4:09

4:09

Fan Mail - Send us a Text Message Today’s topic is about debt recycling and specifically about the need to completely pay down a loan. www.structuring.com.au

1
Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft 27:52

14d ago27:52

27:52

We love to hear from our listeners. Send us a message. Strand Therapeutics' CEO and Co-Founder Jake Becraft joins Erin Harris to discuss genetic regulation and how the company's programmable mRNA constructs combine genes for self-replication derived from RNA viruses with genetically programmed logic circuits that control the location, timing, and i…

1
Podcast #83: Purely Paraplanning - The lang Cat’s Steve Nelson on the findings from the recent State of the Advice Nation report 22:34

21d ago22:34

22:34

Are you a paraplanner? Or maybe you’re an adviser or wealth manager who works with paraplanners? If so, this week’s podcast is for you. This week, Sue and Brandon speak to The Lang Cat’s Steve Nelson about their sixth annual State of the Advice Nation report – all about Paraplanning. It’s refreshing to hear such an influential and successful organi…

1
I&P Podcast #5: Why protection is the key to your clients’ financial resilience, with Lloyds Banking Group’s Rose St. Louis 17:09

22d ago17:09

17:09

On this, the latest Insurance & Protection special edition of our IFA Talk podcast, Sue and Brandon are joined by the highly charismatic and influential voice that is Rose St Louis, Protection Director at Lloyds Banking Group. Their conversation with Rose, formerly a financial adviser herself, is perfect for today’s Consumer Duty landscape. Not onl…

1
127. Claiming Interest on the Main Residence After Renting it Out 5:26

24d ago5:26

5:26

Fan Mail - Send us a Text Message Today’s topic is claiming interest on the main residence after you have moved out. www.structuring.com.auBy Terryw

1
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko 14:52

28d ago14:52

14:52

We love to hear from our listeners. Send us a message. Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.…

1
Podcast #82: What have been the main impacts of Consumer Duty on advisers so far? With Benchmark’s Gillian Hepburn 22:37

1M ago22:37

22:37

Sue and Brandon’s guest on this week’s IFA Talk is Gillian Hepburn, Commercial Director of Benchmark, a leading provider of financial planning solutions and a part of the Schroders Group. In this episode, their conversation drills down into why Consumer Duty is about evolution not revolution and also some of the finer points about how the industry …

1
Accountancy Insights: Corporate reporting update and VAT on private hire vehicles 20:02

1M ago20:02

20:02

In this episode, we discuss important developments in corporate reporting, including amendments to UK GAAP, new standards IFRS18 and IFRS19, and the timeline for implementing IFRS S1 and IFRS S2. We also discuss the evolving VAT treatment of private hire vehicles as a result of recent court cases and how the Treasury may seek to respond. Philippa L…

1
The Logistics of Cell & Gene Therapy – From Benchmarking to Standardization (Part 2) 21:25

1M ago21:25

21:25

In Part 2 of our conversation, Scott Ohanesian, QuickSTAT’s senior VP of Commercial Operations, and Mike Sweeney, QuickSTAT's Global Head of Strategy for CGT and Direct to Patient Products discuss the various challenges around the logistics of Cell & Gene Therapy – what to look out for and the importance of being prepared. We also look forward and …

1
ICAEW Insights In Focus: AI in audit - the good, the bad and the ugly 39:57

1M ago39:57

39:57

In this ICAEW Insights In Focus episode, we discuss the use of artificial intelligence in audit. Depending on who you talk to, generative AI is either going to revolutionise the way auditors work or replace certain roles in the sector entirely. The truth probably lies somewhere in between. So, how are auditors beginning to use AI? And how can pract…

1
Podcast #81: Should CGT replace IHT? Talking tax fallout after the Spring Budget with Ex-HMRC tax inspector, Gravita’s Tom Adcock 26:21

1M ago26:21

26:21

Sue and Brandon’s guest on the podcast today is Tom Adcock, Tax Partner at Gravita – and a former HMRC tax inspector.By IFA Magazine

1
The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley 25:21

1M ago25:21

25:21

We love to hear from our listeners. Send us a message. Dr. Bambi Grilley is Professor of Pediatrics and the Director of Clinical Research and Early Product Development for the Center of Cell and Gene Therapy (CAGT) at Baylor College of Medicine AND she is Chief Regulatory Officer at ISCT. Dr. Grilley talks to us about her role as CRO at ISCT and th…

1
126. Gift or Lend to a Discretionary Trust 4:03

1M ago4:03

4:03

Fan Mail - Send us a Text Message Today I’m talking about gifting or lending money to a new discretionary trust. www.structuring.com.auBy Terryw

1
Dr. Bruce Levine on ISCT and the Future of CAR-T 31:49

1M ago31:49

31:49

We love to hear from our listeners. Send us a message. In anticipation of ISCT 2024 in Vancouver, Canada, Dr. Bruce Levine is back on Cell & Gene: The Podcast to share information about the event as well as his expertise on the future of CAR-T therapy for solid tumors, autoimmune disease, and more. He talks about his time and learnings as President…

1
I&P Podcast #4: What do protection policies mean for your clients? With Beagle Street’s Ryan Griffin 19:42

1M ago19:42

19:42

In this week’s Insurance and Protection special edition of our IFA Talk podcast, Sue and Brandon’s guest is Ryan Griffin. Ryan is Protection Director at dedicated life insurance provider, Beagle Street.By IFA Magazine

1
Podcast #80: Why MPS providers aren’t all the same - putting the client and adviser outcomes first with 8AM’s Paul Hogg 14:39

2M ago14:39

14:39

Sue and Brandon’s guest this week is Paul Hogg, Head of Distribution at 8AM. 8AM are providers of data-driven investment solutions in the model portfolio space, with a clear evidence and outcomes based focus.By IFA Magazine

1
The Logistics of Cell & Gene Therapy – From Benchmarking to Standardization (Part 1) 24:53

2M ago24:53

24:53

Medical care and scientific research offer some of the most challenging – and developing – areas for global supply chain logistics. And few are more significant– in terms of potential for improving human life and logistics precision required – than Cell & Gene Therapy or CGT. These CGT “medical miracles” bring logistics opportunities and challenges…

1
125. Changing Trustees of a Discretionary Trust 4:40

2M ago4:40

4:40

Fan Mail - Send us a Text Message Today's topic is about changing trustees of a discretionary trust. www.structuring.com.auBy Terryw

1
ICAEW Insights: Company size thresholds and CGT on residences 19:59

2M ago19:59

19:59

In this episode of the ICAEW Insights podcast, we discuss upcoming changes to company size thresholds and what they mean for reporting requirements. Plus, with capital gains tax in the headlines, we explore the rules and restrictions when it comes to selling residential property. Philippa Lamb is joined by Sally Baker, Head of Corporate Reporting S…

1
CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant 18:51

2M ago18:51

18:51

We love to hear from our listeners. Send us a message. Dr. Marcus Conant is CMO at Addimmune, a biotech startup developing a cell therapy for HIV that spun out of cell and gene therapy biotech American Gene Technologies (AGT). He spent his career on the front lines of HIV treatment and research and remains an advocate for the HIV patient. He formed…

1
Podcast #79: Is it time to rethink property funds? With Gravis’ Matthew Norris 15:42

2M ago15:42

15:42

In this conversation with Sue and Brandon, Matthew Norris, Head of Real Estate Securities and adviser to the VT Gravis Digital Infrastructure Income and VT Gravis UK Listed Property strategies at Gravis, drills down into exactly how it’s changed, into why it’s no longer about offices and shopping centres. As he explains, it’s now all about next gen…

1
ICAEW Insights In Focus: Lessons in leadership from ICAEW's CEO 33:40

2M ago33:40

33:40

In this special bonus episode of Insights In Focus, we meet new ICAEW CEO Alan Vallance to discuss the leadership lessons of his career. Alan is an ICAEW Chartered Accountant and joined the Institute as CEO in April 2024. His career has spanned various sectors and countries, as well as detailed experience in leading membership bodies RIBA and the C…

1
M&P Podcast #8: The importance of having a survey when buying property with Matthew Cumber 14:32

2M ago14:32

14:32

Our guest on this week’s special Mortgage and Property edition of IFA Talk is Matthew Cumber, MD of Countrywide Surveying. Countrywide are one of the largest surveyors in the UK with around 500 employed surveyors on the team. Tune in to hear Matthew explaining in detail to Sue and Brandon all about the different types of survey that buyers can choo…

1
124. Building on Vacant Land and the CGT Exemption 3:11

2M ago3:11

3:11

Fan Mail - Send us a Text Message Today I’m talking about the main residence exemption for capital gains tax when building on vacant land. www.structuring.com.auBy Terryw

1
Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah 29:39

2M ago29:39

29:39

We love to hear from our listeners. Send us a message. BlueRock Therapeutics' SVP Head of Development, Dr. Ahmed Enayetallah, joins Cell & Gene: The Podcast Host, Erin Harris, to discuss the company's phase I clinical trial for Parkinson’s disease, which continues to show positive trends at 18 months. They cover the important role induced pluripote…

1
Podcast #78: Is now the time for more defensive assets within an investment strategy? with Ninety One’s Jason Borbora-Sheen 15:24

2M ago15:24

15:24

In today’s podcast, Sue and Brandon thought it was the ideal time to talk about defensive assets and find out where there might be some decent investment opportunities for those looking to diversify their portfolios just now. This week’s guest– a friend of the podcast as this is his third time on IFA Talk - is Jason Borbora Sheen, Diversified Incom…

1
I&P Podcast #3: Family Income Benefit – an under-advised protection product with Shelley Read, Royal London 16:08

3M ago16:08

16:08

Shelley Read, Senior Protection Technical Manager at Royal London joins Jenny and Brandon to give our listeners all they need to know about FIB. As well as highlighting what types of clients could benefit from having conversations around this type of protection which should help advisers identify opportunities to help those most in need.…

1
ICAEW Insights In Focus: So you want to be a leader? 30:28

3M ago30:28

30:28

In this Insights In Focus episode, we discuss how accountants can build the skills needed to take on leadership and executive roles during their careers. In a recent report by the Financial Times, one anonymous headhunter was quoted as saying: “If America is run by lawyers, then the UK is run by accountants.” It’s backed up by the data, too: around…

1
123. Who Should be the Trustee of a Discretionary Trust 4:53

3M ago4:53

4:53

Fan Mail - Send us a Text Message Today’s topic is who should be the trustee of a discretionary trust. www.structuring.com.auBy Terryw

1
Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang 23:08

3M ago23:08

23:08

We love to hear from our listeners. Send us a message. In 2021 on Episode 13, Vor Bio’s President and CEO, Dr. Robert Ang shared data about the company’s lead engineered hematopoietic cell (eHSC) product candidate. Dr. Ang is back to talk to Cell & Gene: The Podcast Host, Erin Harris, about how Vor has treated 8 patients demonstrating clinical proo…

1
M&P Podcast #7: Why the green agenda is important to the housing market with Coventry’s Jonathan Stinton 13:36

3M ago13:36

13:36

Back for his second visit to the IFA Talk Studio, our guest this week is Jonathan Stinton, Head of Intermediary Relationships at Coventry Building Society. Coventry has recently produced an influential report entitled “Beyond the Bricks” which looks in detail at what a green housing market really would look like. It’s an interesting conversation an…

1
ICAEW Insights: A busy new tax year, plus progress on the Economic Crime Act 17:54

3M ago17:54

17:54

In this episode, we discuss why the arrival of the 2024/25 tax year is particularly busy for accountants, and the main changes to be aware of from 6 April. Plus, six months on from the passing of the Economic Crime and Corporate Transparency Act, we learn what progress has been made to enact its various provisions. To shed light on those two topics…

1
Podcast #77: Later-life finance options for clients. With Standard Life Home Finance’s Kay Westgarth 13:57

3M ago13:57

13:57

Helping older clients to raise finance is becoming an increasingly important part of the advice process. Our guest on IFA Talk today is Kay Westgarth, Sales Director at Standard Life Home Finance. Kay is highly experienced in this area and is keen to raise awareness amongst advisers of the range of later life finance options for the over-55s.…

1
122. SMSF Borrowing to Buy Property 6:24

3M ago6:24

6:24

Fan Mail - Send us a Text Message Today’s topic is self managed super funds (SMSF) borrowing to buy property. www.structuring.com.auBy Terryw

1
Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan 19:37

3M ago19:37

19:37

We love to hear from our listeners. Send us a message. Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio's plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational high-prec…

1
M&P Podcast #6 Sustainability special: How can retrofitting shake up the mortgage market? With Mike Lindsay-Bailey and Thomas Farquhar 16:21

3M ago16:21

16:21

In this eco-friendly edition of our IFA Talk Mortgage and Property special podcast, Sue and Brandon have two great guests to share their knowledge and insight about retrofitting homes and installing energy-saving tech – and the financing of such projects.By IFA Magazine

1
ICAEW Insights In Focus: Does Britain have a farming problem? 24:36

4M ago24:36

24:36

In this Insights In Focus episode, we discuss how changes to the funding of British farms could affect the UK’s broader economic resilience. As a result of Brexit, British farms will stop benefiting from the EU Common Agricultural Policy by the end of 2027. The policy paid subsidies largely regardless of land use. Now, farmers need to transition to…

1
I&P Podcast #2: What’s going on in protection and why does it matter? With MetLife’s Rich Horner 15:03

4M ago15:03

15:03

Rich Horner, Head of Individual Protection at MetLife UK is Sue and Brandon’s guest on this week’s IFA Talk podcast and is particularly focused on growing the reputation and take up of protection products as a key part of the financial planning process.By IFA Magazine

1
121. Getting Money Out of a Bucket Company 4:38

4M ago4:38

4:38

Fan Mail - Send us a Text Message Today I’m talking about getting money out of a bucket company. www.structuring.com.auBy Terryw

1
Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D. 17:17

4M ago17:17

17:17

We love to hear from our listeners. Send us a message. On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Life Biosciences' CSO, Sharon Rosenzweig-Lipson, Ph.D., about the Boston-based biotech's cellular rejuvenation therapies for the treatment of age-related diseases. They cover Life Biosciences' lead program, a gene therapy ca…

1
AllSaints' James Reid on Endless Engagement Opportunities with Mobile Apps 30:44

4M ago30:44

30:44

In this episode, we’re joined by James Reid, chief innovation officer at AllSaints. James brings a wealth of experience from both software and sales roles across various consumer goods companies and retailers. We explore AllSaints' journey, from re-platforming and shepherding innovation across the enterprise to the success of their consumer app, bo…

1
Podcast #76: SDR labels - The future of the UK sustainability-labelled funds landscape. With Morningstar’s Hortense Bioy 17:24

4M ago17:24

17:24

On this week’s podcast, Jenny and Brandon speak to Hortense Bioy, Global Director of Sustainability Research at Morningstar. Morningstar has recently undertaken some useful research U.K. Sustainability Disclosure Requirements: An early analysis | Morningstar, to explore what the landscape of UK sustainability-labelled funds may look like in the fut…

1
ICAEW Insights In Focus: Budget 2024 – does it change anything? 26:04

4M ago26:04

26:04

In this Insights In Focus episode, we discuss the contents of the 2024 Spring Budget and their likely impacts on the UK economy. The Spring Budget was delivered against the backdrop of recession and persistent inflation. While the Chancellor had better-than-expected headroom for delivering tax cuts, the UK economy and its public finances are still …

1
Podcast #75: Looking back at the Budget and ahead to International Women’s Day – an expert perspective, with Dynamic Planner’s Steph Willcox 16:02

4M ago16:02

16:02

This week’s IFA talk is a Budget Special! Where we highlight the changes announced in yesterday’s Spring Budget 2024 that advisers need to be most aware of. Joining Jenny and Sue this week is Steph Willcox, Head Actuary at Dynamic Planner. Bringing a wealth of knowledge about the financial services industry, Steph shares what impact she thinks the …

Podcasts Worth a Listen

CGT Podcasts

Podcasts Worth a Listen

Quick Reference Guide